Orthopaedic Implants Worth Rs 70L Seized By FDA

Nagpur: The Food and Drug Administration (FDA) team seized orthopaedic implants worth around Rs 70 lakh from a stockist during a raid at Dhantoli last week. The implants, mostly imported, were stocked without licences.

The team, under supervision of FDA joint commissioner (drug), Viraj Paunikar, served a notice to the stockist to furnish bills and invoices within three days.

The team comprising drug inspectors Neeraj Lohkare, Prashant Ramteke, Manish Chaudhuri and Shehnaz Taji acted on a tip-off and took action.

“If the stockist provides us bills and invoices, only then the seized materials would be considered legally procured items, else there he would be prosecuted for the irregularity,” said an official adding most of the seized implants were meant to be sent to different private hospitals.

Related Posts

  • Pharma
  • February 17, 2025
  • 93 views
GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gained by 20 percent on Monday, February 17, as brokerages like ICICI Securities and Motilal Oswal continue to maintain positive rating of the stock. GlaxoSmithKline Pharmaceuticals Ltd…

  • Pharma
  • February 17, 2025
  • 82 views
Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Shares of Glenmark Pharmaceuticals Ltd rose 4% on February 17 after the firm gave a strong guidance for FY26 and it returned to black in the December quarter. The drugmaker…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wow! What a Change of Heart in Practitioners of Allopathy!

Wow! What a Change of Heart in Practitioners of Allopathy!

GSK Pharma shares gain 20% following strong Q3FY25 results

GSK Pharma shares gain 20% following strong Q3FY25 results

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

Glenmark Pharma shares rise 4% on Q3 results, FY26 guidance

US Tariffs on pharma: What are the potential impact on Indian drugmakers

US Tariffs on pharma: What are the potential impact on Indian drugmakers

Twin Health bats a1000 before enters Digital Health NY 100

Twin Health bats a1000 before enters Digital Health NY 100

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%

US tariff jitters rock pharma stocks; Sun Pharma, Lupin, Dr Reddy’s slump 2-4%